ACKR3 and coronary artery disorder: However, in the migration assay, the migration capacity had no significant difference among CAD-EOCs, Ad5/GFP-transduced CAD-EOCs, and Ad5/CXCR7-transduced CAD-EOCs (p <0.05) (Fig 2G and 2H).